Back to BMRN
STATE STREET CORP BMRN Position History
BioMarin Pharmaceutical Inc. • Healthcare
Quarters held
27
Latest value
$14.8M
Q2 2026
Peak value
$793.3M
First seen
Q4 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2023 | $649M |
| Q4 2023 | $11.4M |
| Q4 2023 | $13.2M |
| Q1 2024 | $602.2M |
| Q1 2024 | $11.3M |
| Q1 2024 | $11.9M |
| Q2 2024 | $793.3M |
| Q2 2024 | $10M |
| Q2 2024 | $12.2M |
| Q3 2024 | $620.2M |
| Q3 2024 | $10.9M |
| Q4 2024 | $598.9M |
| Q4 2024 | $11.9M |
| Q1 2025 | $598.3M |
| Q1 2025 | $11.4M |
| Q2 2025 | $486.4M |
| Q2 2025 | $11M |
| Q3 2025 | $474.7M |
| Q3 2025 | $11.7M |
| Q4 2025 | $447.1M |
| Q4 2025 | $12.4M |
| Q1 2026 | $412.1M |
| Q1 2026 | $11.2M |
| Q2 2026 | $446.4M |
| Q2 2026 | $14.8M |
| Q2 2026 | $446.4M |
| Q2 2026 | $14.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $14.8M | 15.17M | — | — |
| Q2 2026 | $446.4M | 7.80M | — | — |
| Q2 2026 | $14.8M | 15.17M | — | — |
| Q2 2026 | $446.4M | 7.80M | — | — |
| Q1 2026 | $11.2M | 11.57M | — | — |
| Q1 2026 | $412.1M | 7.30M | — | — |
| Q4 2025 | $12.4M | 12.89M | — | — |
| Q4 2025 | $447.1M | 7.52M | — | — |
| Q3 2025 | $11.7M | 12.24M | — | — |
| Q3 2025 | $474.7M | 8.76M | — | — |
| Q2 2025 | $11M | 11.62M | — | — |
| Q2 2025 | $486.4M | 8.85M | — | — |
| Q1 2025 | $11.4M | 11.97M | — | — |
| Q1 2025 | $598.3M | 8.46M | — | — |
| Q4 2024 | $11.9M | 12.82M | — | — |
| Q4 2024 | $598.9M | 9.11M | — | — |
| Q3 2024 | $10.9M | 11.42M | — | — |
| Q3 2024 | $620.2M | 8.82M | — | — |
| Q2 2024 | $12.2M | 12.67M | — | — |
| Q2 2024 | $10M | 10.03M | — | — |
| Q2 2024 | $793.3M | 9.64M | — | — |
| Q1 2024 | $11.9M | 11.92M | — | — |
| Q1 2024 | $11.3M | 11.53M | — | — |
| Q1 2024 | $602.2M | 6.90M | — | — |
| Q4 2023 | $13.2M | 12.82M | — | — |
| Q4 2023 | $11.4M | 11.53M | — | — |
| Q4 2023 | $649M | 6.73M | — | — |
Other funds holding BMRN
$1.4B
$1.3B
$1.3B
$1.3B
$1.3B
$1.2B
$1.2B
$1.1B